+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Urinary Tract Obstruction Treatment Devices Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6158633
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Urinary Tract Obstruction Treatment Devices Market is projected to reach USD 814.93 Million in 2026. It is expected to continue growing at a CAGR of 8.71%, reaching USD 1.34 Billion by 2032.

Urinary Tract Obstruction Treatment Devices: Executive Overview

Urinary tract obstruction treatment devices include stents, catheters, nephrostomy systems, dilation tools, stone-removal devices, and related drainage or endoscopic technologies used to restore or maintain urinary flow. Clinical priorities center on timely decompression, infection control, preservation of renal function, minimizing trauma, and reducing repeat interventions. Demand is shaped by urinary stones, benign prostatic obstruction, malignancy, congenital conditions, postoperative complications, and aging-related comorbidities. Device selection depends on obstruction location, severity, duration, anatomy, infection status, renal function, and available clinical expertise.

Clinical Pathways Are Shifting Toward Less Invasive, Patient-Centered Care

Treatment pathways are increasingly organized around rapid diagnosis, urgent drainage when infection or renal compromise is present, and definitive correction after stabilization. Endoscopic and image-guided approaches can reduce surgical burden for appropriate patients, while improvements in materials, coatings, drainage design, and delivery systems aim to improve patency and comfort. Hospitals are also placing greater emphasis on reducing device-associated infection, migration, encrustation, emergency readmissions, and avoidable exchanges. These shifts favor technologies that support predictable placement, shorter recovery, clear follow-up protocols, and compatibility with multidisciplinary urology, radiology, and emergency-care workflows.

Artificial Intelligence Strengthens Detection, Planning, and Follow-Up

Artificial intelligence can support urinary obstruction care through image interpretation, stone and hydronephrosis detection, procedure planning, risk stratification, and identification of patients requiring urgent escalation. In operating rooms and interventional settings, software-assisted navigation may improve anatomical visualization and documentation, while remote monitoring and structured data analysis can help identify complications such as infection, migration, or recurrent obstruction. Clinical value depends on representative training data, transparent validation, cybersecurity, interoperability with imaging and hospital systems, and clinician oversight. AI should augment-not replace-clinical judgment, particularly in emergencies and anatomically complex cases.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America emphasizes minimally invasive care, infection prevention, ambulatory pathways, and integration of advanced imaging and digital records. Europe focuses on guideline-aligned care, device safety, cross-border regulatory requirements, and reducing complications and repeat procedures. Asia-Pacific combines advanced tertiary-center capability with substantial variation in access, making affordability, training, and scalable infrastructure important. Latin America is influenced by uneven availability of specialist services, reimbursement constraints, and the need for durable devices suited to diverse care settings. The Middle East is expanding specialized hospital capacity while prioritizing referral networks and procedural expertise. Africa faces pronounced differences in diagnostic access, emergency decompression capability, supply continuity, and specialist coverage, increasing the importance of adaptable treatment models and workforce development.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Show Distinct System Priorities

ASEAN settings generally require scalable solutions that accommodate differences in healthcare infrastructure, procurement, and specialist availability. BRICS economies combine large and diverse patient populations with domestic manufacturing, access, and affordability priorities that vary substantially by member. The European Union places strong emphasis on coordinated safety, evidence, procurement, and data requirements across member states. G7 systems typically prioritize clinical quality, innovation, value-based procurement, and post-market evidence. GCC countries are investing in specialized care capacity and referral infrastructure while managing dependence on imported technologies and skilled personnel. NATO members share broad interests in resilient medical supply chains, interoperable systems, emergency preparedness, and continuity of care during disruptions, although national health systems and procurement rules remain distinct.

Country Conditions Shape Adoption, Access, and Clinical Workflow

Australia combines advanced specialist care with geographic dispersion that makes referral coordination and remote access important. Brazil and Mexico must address regional disparities, public-system capacity, and affordability alongside specialist expansion. Canada and the United States emphasize minimally invasive pathways, evidence-based procurement, and management of complex or recurrent obstruction, while access can differ by geography and payer. China and India are expanding hospital and manufacturing capabilities but continue to face substantial variation between major centers and less-served areas. Japan prioritizes precision, safety, aging-related care, and procedural efficiency. South Korea combines advanced digital and hospital infrastructure with demand for high-quality minimally invasive treatment. France, Germany, Italy, and Spain operate within mature European clinical and regulatory environments, with attention to reimbursement, quality, and hospital efficiency. The United Kingdom emphasizes guideline-based pathways, centralized evidence review, waiting-time management, and service resilience. Russia faces distinct procurement, infrastructure, and supply-continuity considerations that can influence device availability and clinical standardization.

Industry Leaders Should Prioritize Safety, Interoperability, and Access

Leaders should design portfolios around clinically meaningful outcomes: reliable decompression, low infection and encrustation risk, atraumatic placement, patient comfort, and fewer unplanned exchanges. Evidence programs should reflect real-world populations, recurrent disease, urgent presentations, and diverse care settings rather than relying only on highly selected procedural cohorts. Product development should incorporate interoperable imaging and documentation, cybersecurity, traceability, and AI governance from the outset. Commercial and health-system strategies should pair devices with training, protocol support, inventory resilience, and post-procedure follow-up. Regional adaptation is essential: solutions for tertiary hospitals may require different delivery models, packaging, education, and service support than those used in rural, emergency, or resource-constrained settings.

Methodology: Evidence-Based Synthesis of Clinical, Regulatory, and System Factors

This executive summary uses the defined market scope of urinary tract obstruction treatment devices and synthesizes verified qualitative evidence from clinical practice principles, peer-reviewed medical literature, professional guidance, regulatory considerations, healthcare-system information, and documented technology developments. Analysis is structured across treatment pathways, device characteristics, artificial-intelligence applications, regions, country contexts, and multinational groupings. Insights are interpreted comparatively rather than as market estimates. Claims are screened for clinical relevance, geographic applicability, and evidentiary support, with attention to differences in emergency care, reimbursement, procurement, specialist availability, infrastructure, and data governance. Because device performance and treatment decisions depend on patient anatomy and clinical presentation, conclusions are framed as strategic considerations rather than universal recommendations.

The Market’s Direction Is Defined by Safer Decompression and More Connected Care

Urinary tract obstruction treatment is moving toward earlier recognition, less invasive intervention, stronger infection prevention, and coordinated follow-up. The most durable opportunities will come from devices and care models that perform reliably across urgent and elective settings, integrate with clinical workflows, and reduce the burden of repeat procedures. Artificial intelligence can reinforce these goals when validated and governed appropriately, but implementation must remain clinically led. Industry leaders that combine evidence, usability, workforce support, supply resilience, and regional adaptability will be best positioned to improve outcomes across diverse healthcare environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Urinary Tract Obstruction Treatment Devices Market, by Product Type
7.1. Introduction
7.2. Balloon Dilation Catheter
7.3. Nephrostomy Tube
7.4. Ureteral Stent
7.4.1. Metal Stent
7.4.2. Polymer Stent
7.4.2.1. Polyurethane Stent
7.4.2.2. Silicone Stent
7.5. Urethral Catheter
8. Urinary Tract Obstruction Treatment Devices Market, by Ureteral Obstruction
8.1. Introduction
8.2. Benign Obstruction
8.2.1. Kidney Stone
8.2.2. Ureteral Stricture
8.3. Malignant Obstruction
8.3.1. Bladder Cancer
8.3.2. Cervical Cancer
8.3.3. Prostate Cancer
9. Urinary Tract Obstruction Treatment Devices Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals
9.4. Specialty Clinics
10. Urinary Tract Obstruction Treatment Devices Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Urinary Tract Obstruction Treatment Devices Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Urinary Tract Obstruction Treatment Devices Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Ambu A/S
14.2. B. Braun Melsungen AG
14.3. Boston Scientific Corporation
14.4. Coloplast A/S
14.5. ConMed Corporation
14.6. Cook Medical LLC
14.7. EndoChoice, Inc.
14.8. Karl Storz SE & Co. KG
14.9. Medica S.p.A.
14.10. Medtronic plc
14.11. Olympus Corporation
14.12. Porges Medical GmbH
14.13. Richard Wolf GmbH
14.14. Rochester Medical, Inc.
14.15. Smith & Nephew plc
14.16. Storz Medical AG
14.17. Stryker Corporation
14.18. Teleflex Incorporated
14.19. UroMed Corporation
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Urinary Tract Obstruction Treatment Devices Market, Years Considered for the Study
FIGURE 2. Global Urinary Tract Obstruction Treatment Devices Market, Research Design
FIGURE 3. Global Urinary Tract Obstruction Treatment Devices Market, Research Framework
FIGURE 4. Global Urinary Tract Obstruction Treatment Devices Market, Data Triangulation
FIGURE 5. Global Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2025 vs 2032 (%)
FIGURE 9. Global Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Urinary Tract Obstruction Treatment Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Urinary Tract Obstruction Treatment Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Urinary Tract Obstruction Treatment Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Urinary Tract Obstruction Treatment Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Urinary Tract Obstruction Treatment Devices Market Segmentation & Coverage
TABLE 2. Global Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Balloon Dilation Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Balloon Dilation Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Balloon Dilation Catheter Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Nephrostomy Tube Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Nephrostomy Tube Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Nephrostomy Tube Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Ureteral Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Ureteral Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Ureteral Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Metal Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Metal Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Metal Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Polymer Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Polymer Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Polymer Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Polyurethane Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Polyurethane Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Polyurethane Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Silicone Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Silicone Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Silicone Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Urethral Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Urethral Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Urethral Catheter Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 29. Global Benign Obstruction Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Benign Obstruction Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Benign Obstruction Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Kidney Stone Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Kidney Stone Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Kidney Stone Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Ureteral Stricture Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Ureteral Stricture Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Ureteral Stricture Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Malignant Obstruction Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Malignant Obstruction Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Malignant Obstruction Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Bladder Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Bladder Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Bladder Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Cervical Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Cervical Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Cervical Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 51. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. North America Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 71. North America Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 72. North America Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 73. North America Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 74. North America Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 75. North America Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 76. North America Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Latin America Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Latin America Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 79. Latin America Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 80. Latin America Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 81. Latin America Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 82. Latin America Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 83. Latin America Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 84. Latin America Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Europe Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Europe Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. Europe Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 88. Europe Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 89. Europe Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 90. Europe Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 91. Europe Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 92. Europe Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Middle East Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Middle East Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 95. Middle East Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 96. Middle East Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 97. Middle East Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 98. Middle East Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 99. Middle East Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 100. Middle East Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Africa Urinary Tract Obstruction Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Africa Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 103. Africa Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 104. Africa Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 105. Africa Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 106. Africa Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 107. Africa Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 108. Africa Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. Global Urinary Tract Obstruction Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Urinary Tract Obstruction Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. ASEAN Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 113. ASEAN Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 114. ASEAN Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 115. ASEAN Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 116. ASEAN Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 117. ASEAN Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. GCC Urinary Tract Obstruction Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. GCC Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. GCC Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 121. GCC Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 122. GCC Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 123. GCC Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 124. GCC Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 125. GCC Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. European Union Urinary Tract Obstruction Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. European Union Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. European Union Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 129. European Union Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 130. European Union Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 131. European Union Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 132. European Union Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 133. European Union Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. BRICS Urinary Tract Obstruction Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. BRICS Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. BRICS Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 137. BRICS Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 138. BRICS Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 139. BRICS Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 140. BRICS Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 141. BRICS Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. G7 Urinary Tract Obstruction Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. G7 Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. G7 Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 145. G7 Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 146. G7 Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 147. G7 Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 148. G7 Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 149. G7 Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. NATO Urinary Tract Obstruction Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. NATO Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. NATO Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 153. NATO Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 154. NATO Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 155. NATO Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 156. NATO Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 157. NATO Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Global Urinary Tract Obstruction Treatment Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. United States Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 160. United States Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. United States Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 162. United States Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 163. United States Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 164. United States Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 165. United States Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 166. United States Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Canada Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 168. Canada Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Canada Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 170. Canada Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 171. Canada Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 172. Canada Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 173. Canada Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 174. Canada Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Mexico Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 176. Mexico Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Mexico Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 178. Mexico Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 179. Mexico Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 180. Mexico Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 181. Mexico Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 182. Mexico Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Brazil Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 184. Brazil Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. Brazil Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 186. Brazil Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 187. Brazil Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 188. Brazil Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 189. Brazil Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 190. Brazil Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. United Kingdom Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 192. United Kingdom Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. United Kingdom Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 194. United Kingdom Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 195. United Kingdom Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 196. United Kingdom Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 197. United Kingdom Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 198. United Kingdom Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Germany Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 200. Germany Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. Germany Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 202. Germany Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 203. Germany Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 204. Germany Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 205. Germany Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 206. Germany Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. France Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 208. France Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. France Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 210. France Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 211. France Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 212. France Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 213. France Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 214. France Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Russia Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 216. Russia Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. Russia Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 218. Russia Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 219. Russia Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 220. Russia Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 221. Russia Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 222. Russia Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Italy Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 224. Italy Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. Italy Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 226. Italy Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 227. Italy Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 228. Italy Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 229. Italy Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 230. Italy Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Spain Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 232. Spain Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. Spain Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 234. Spain Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 235. Spain Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 236. Spain Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 237. Spain Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 238. Spain Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. China Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 240. China Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. China Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 242. China Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 243. China Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 244. China Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 245. China Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 246. China Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. India Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 248. India Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 249. India Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 250. India Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 251. India Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 252. India Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 253. India Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 254. India Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. Japan Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 256. Japan Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. Japan Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 258. Japan Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 259. Japan Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 260. Japan Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 261. Japan Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 262. Japan Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Australia Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 264. Australia Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 265. Australia Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 266. Australia Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 267. Australia Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 268. Australia Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 269. Australia Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 270. Australia Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. South Korea Urinary Tract Obstruction Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 272. South Korea Urinary Tract Obstruction Treatment Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 273. South Korea Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Stent, 2017-2032 (USD Million)
TABLE 274. South Korea Urinary Tract Obstruction Treatment Devices Market Size, by Polymer Stent, 2017-2032 (USD Million)
TABLE 275. South Korea Urinary Tract Obstruction Treatment Devices Market Size, by Ureteral Obstruction, 2017-2032 (USD Million)
TABLE 276. South Korea Urinary Tract Obstruction Treatment Devices Market Size, by Benign Obstruction, 2017-2032 (USD Million)
TABLE 277. South Korea Urinary Tract Obstruction Treatment Devices Market Size, by Malignant Obstruction, 2017-2032 (USD Million)
TABLE 278. South Korea Urinary Tract Obstruction Treatment Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Global Urinary Tract Obstruction Treatment Devices Market Share, by Key Player, 2025
TABLE 280. Global Urinary Tract Obstruction Treatment Devices Market, Key Experts

Companies Mentioned

  • Ambu A/S
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Coloplast A/S
  • ConMed Corporation
  • Cook Medical LLC
  • EndoChoice, Inc.
  • Karl Storz SE & Co. KG
  • Medica S.p.A.
  • Medtronic plc
  • Olympus Corporation
  • Porges Medical GmbH
  • Richard Wolf GmbH
  • Rochester Medical, Inc.
  • Smith & Nephew plc
  • Storz Medical AG
  • Stryker Corporation
  • Teleflex Incorporated
  • UroMed Corporation